Monday, October 05, 2009

Woe Is Lowly Garlic Clove

Woe is lowly garlic clove, beloved as a spice in foods, but continues to disappoint as a cholesterol-lowering agent. The latest study compared a fresh garlic clove with two commercially available garlic pills, one known to produce allicin (Garlicin), garlic's primary active ingredient, and the other, aged garlic with no allicin. There was no significant change in circulating cholesterol numbers after six months of use the three garlic sources compared to taking an inactive placebo tablet. [Archives of Internal Medicine 167: 346-53, 2007] But before modern medicine gives its final "thumbs down" on garlic, maybe the researchers are on the wrong street. Read more...

No comments: